Prediction of the emergence of HBV mutant by the antiviral treatment by using next-generation sequencer
Not Applicable
- Conditions
- chronic hepatitis B
- Registration Number
- JPRN-UMIN000018701
- Lead Sponsor
- Graduate School of Medicine, Osaka City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
(1) the patients who are not detect HBVDNA in peripheral blood (2) the patients who cannot consult our department periodically (3) the patients who are not appropriate to entry for this examination by doctors
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of the rate of the wild and mutant strain before medical treatment, and the rate of each stock under medical treatment
- Secondary Outcome Measures
Name Time Method